- Home
- CPRX vs BBUC Comparison
CPRX vs BBUC Comparison
Compare CPRX & BBUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- BBUC
- Stock Information
- Founded
- CPRX 2002
- BBUC 2022
- Country
- CPRX United States
- BBUC United States
- Employees
- CPRX N/A
- BBUC N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- BBUC
- Sector
- CPRX Health Care
- BBUC
- Exchange
- CPRX Nasdaq
- BBUC Nasdaq
- Market Cap
- CPRX 2.6B
- BBUC 2.4B
- IPO Year
- CPRX 2006
- BBUC N/A
- Fundamental
- Price
- CPRX $20.02
- BBUC $34.96
- Analyst Decision
- CPRX Strong Buy
- BBUC
- Analyst Count
- CPRX 5
- BBUC 0
- Target Price
- CPRX $33.20
- BBUC N/A
- AVG Volume (30 Days)
- CPRX 1.5M
- BBUC 92.8K
- Earning Date
- CPRX 11-05-2025
- BBUC 11-01-2025
- Dividend Yield
- CPRX N/A
- BBUC 0.72%
- EPS Growth
- CPRX 183.96
- BBUC N/A
- EPS
- CPRX 1.65
- BBUC N/A
- Revenue
- CPRX $558,499,000.00
- BBUC $8,240,000,000.00
- Revenue This Year
- CPRX $16.51
- BBUC N/A
- Revenue Next Year
- CPRX $9.58
- BBUC N/A
- P/E Ratio
- CPRX $12.10
- BBUC N/A
- Revenue Growth
- CPRX 28.55
- BBUC 6.96
- 52 Week Low
- CPRX $19.15
- BBUC $21.52
- 52 Week High
- CPRX $26.58
- BBUC $35.54
- Technical
- Relative Strength Index (RSI)
- CPRX 46.35
- BBUC 60.47
- Support Level
- CPRX $19.66
- BBUC $33.56
- Resistance Level
- CPRX $20.52
- BBUC $34.58
- Average True Range (ATR)
- CPRX 0.67
- BBUC 1.06
- MACD
- CPRX 0.03
- BBUC -0.02
- Stochastic Oscillator
- CPRX 42.08
- BBUC 81.36
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.